J A Double

2.1k total citations · 1 hit paper
29 papers, 1.7k citations indexed

About

J A Double is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, J A Double has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Biotechnology. Recurrent topics in J A Double's work include Cancer Research and Treatments (7 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Cancer therapeutics and mechanisms (4 papers). J A Double is often cited by papers focused on Cancer Research and Treatments (7 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Cancer therapeutics and mechanisms (4 papers). J A Double collaborates with scholars based in United Kingdom, Germany and North Macedonia. J A Double's co-authors include Ian J. Stratford, Paul Workman, M J Glennie, Eric O. Aboagye, Lloyd R. Kèlland, Sue Eccles, David Farningham, Stephen R. Wedge, Allan Balmain and Frances R. Balkwill and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Medicinal Chemistry and British Journal of Cancer.

In The Last Decade

J A Double

29 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for the welfare and use of animals in cancer research

2010 1.1k citations Paul Workman, Eric O. Aboagye et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J A Double United Kingdom	15	821	523	374	191	185	29	1.7k
Gillian Paine-Murrieta United States	16	1.4k 1.7×	323 0.6×	545 1.5×	137 0.7×	168 0.9×	18	2.1k
Donald J. Dykes United States	16	681 0.8×	743 1.4×	265 0.7×	123 0.6×	101 0.5×	27	1.7k
Brent C. Behrens United States	15	1.2k 1.4×	768 1.5×	222 0.6×	197 1.0×	142 0.8×	19	2.1k
Michael I. Walton United Kingdom	28	1.7k 2.1×	719 1.4×	442 1.2×	308 1.6×	183 1.0×	49	2.5k
Wilma M. McKoy United States	10	1.2k 1.4×	719 1.4×	229 0.6×	166 0.9×	177 1.0×	14	2.1k
Hans R. Hendriks Netherlands	21	580 0.7×	321 0.6×	252 0.7×	186 1.0×	259 1.4×	49	1.3k
Ana M. Tari United States	31	1.7k 2.1×	708 1.4×	367 1.0×	161 0.8×	171 0.9×	65	2.6k
Marc Lacroix Belgium	18	1.1k 1.3×	972 1.9×	563 1.5×	79 0.4×	148 0.8×	42	2.2k
Alexander D. Lewis United Kingdom	19	855 1.0×	289 0.6×	354 0.9×	127 0.7×	58 0.3×	25	1.4k
Matilde Olivé United States	13	1.2k 1.4×	978 1.9×	444 1.2×	89 0.5×	153 0.8×	18	2.1k

Countries citing papers authored by J A Double

Since Specialization

Citations

This map shows the geographic impact of J A Double's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Double with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Double more than expected).

Fields of papers citing papers by J A Double

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Double. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Double. The network helps show where J A Double may publish in the future.

Co-authorship network of co-authors of J A Double

This figure shows the co-authorship network connecting the top 25 collaborators of J A Double. A scholar is included among the top collaborators of J A Double based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Double. J A Double is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Workman, Paul, Eric O. Aboagye, Frances R. Balkwill, et al.. (2010). Guidelines for the welfare and use of animals in cancer research. British Journal of Cancer. 102(11). 1555–1577. 1076 indexed citations breakdown →

Ruparelia, Ketan C., et al.. (2000). Enhancement of the radio-and chemotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.. British Journal of Cancer. 82. 4 indexed citations

Calabrese, Christopher, Paul M. Loadman, Lee Yong Lim, et al.. (1999). In Vivo Metabolism of the Antitumor Imidazoacridinone C1311 in the Mouse and In Vitro Comparison with Humans. Drug Metabolism and Disposition. 27(2). 240–245. 11 indexed citations

Jenkins, T.C., et al.. (1999). Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311. British Journal of Cancer. 81(2). 367–375. 34 indexed citations

Augustin, Ewa, et al.. (1998). C-1311. Drugs of the Future. 23(7). 702–702. 16 indexed citations

Phillips, Roger M., J. Pearce, Paul M. Loadman, et al.. (1998). Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs.. PubMed. 58(23). 5263–6. 37 indexed citations

Double, J A, et al.. (1996). Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer. British Journal of Cancer. 74(9). 1369–1374. 40 indexed citations

Collard, J.G., et al.. (1995). EO9: relationship between DT-diaphorase levels and response in vitro and in vivo. British Journal of Cancer. 71(6). 1199–1203. 28 indexed citations

Double, J A, et al.. (1995). Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid. British Journal of Cancer. 71(6). 1204–1209. 45 indexed citations

10.

Hanks, Steven K., et al.. (1993). Methods for liquid chromatographic analysis of tamoxifen, tamoxifen metabolites and their geometric isomers in biological samples. Analytical Proceedings. 30(3). 161–163. 1 indexed citations

11.

Double, J A, et al.. (1993). Flavone acetic acid—from laboratory to clinic and back. Anti-Cancer Drugs. 4(1). 3–17. 43 indexed citations

12.

Bibby, M C, Roger M. Phillips, & J A Double. (1991). The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours. British Journal of Cancer. 63(4). 541–545. 1 indexed citations

13.

Bibby, M C, Roger M. Phillips, J A Double, & Graziella Pratesi. (1991). Anti-tumour activity of flavone acetic acid (NSC 347512) in mice – influence of immune status. British Journal of Cancer. 63(1). 57–62. 44 indexed citations

14.

Bibby, M C, et al.. (1991). Flavone Acetic Acid: Is Vascular Shutdown the Crucial Mechanism of Action. International Journal of Radiation Biology. 60(1-2). 395–399. 5 indexed citations

15.

Verboom, Willem, David N. Reinhoudt, P. Lelieveld, et al.. (1989). Synthesis, mechanism of action, and biological evaluation of mitosenes. Journal of Medicinal Chemistry. 32(7). 1612–1620. 81 indexed citations

16.

Bibby, M C, et al.. (1989). Reduction of Tumor Blood Flow by Flavone Acetic Acid: A Possible Component of Therapy. JNCI Journal of the National Cancer Institute. 81(3). 216–220. 108 indexed citations

17.

Bibby, M C, et al.. (1988). Experimental anti-tumor effects of flavone acetic acid (LM975).. PubMed. 280. 243–6. 5 indexed citations

18.

Bibby, M.C., J A Double, & Christopher M. Morris. (1988). Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours. European Journal of Cancer and Clinical Oncology. 24(8). 1361–1364. 15 indexed citations

19.

Double, J A, M.C. Bibby, & Paul M. Loadman. (1987). Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon. British Journal of Cancer. 54(4). 595–600. 22 indexed citations

20.

Double, J A, et al.. (1987). The Comparative Effects of Cytotoxic Agents on the Numbers of Oocytes in Mice. PubMed. 11. 152–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact